We are live on ! Find out more

1,745 hedge funds and large institutions have $107B invested in Merck in 2016 Q1 according to their latest regulatory filings, with 98 funds opening new positions, 754 increasing their positions, 675 reducing their positions, and 83 closing their positions.

New
Increased
Maintained
Reduced
Closed

18% more first-time investments, than exits

New positions opened: 98 | Existing positions closed: 83

12% more repeat investments, than reductions

Existing positions increased: 754 | Existing positions reduced: 675

1.44% more ownership

Funds ownership: 77.23%78.67% (+1.4%)

1% more funds holding in top 10

Funds holding in top 10: 105106 (+1)

1% less funds holding

Funds holding: 1,7551,745 (-10)

5% less capital invested

Capital invested by funds: $112B → $107B (-$5.17B)

10% less call options, than puts

Call options by funds: $693M | Put options by funds: $769M

Holders
1,745
Holders Change
-10
Holders Change %
-0.57%
% of All Funds
46.48%
Holding in Top 10
106
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+0.95%
% of All Funds
2.82%
New
98
Increased
754
Reduced
675
Closed
83
Calls
$693M
Puts
$769M
Net Calls
-$76.2M
Net Calls Change
-$112M
Name Holding Trade Value Shares
Change
Change in
Stake
TWM
1026
Torch Wealth Management
Ohio
$1.47M +$196 +4 +0%
CCA
1027
Checchi Capital Advisers
California
$1.47M +$135K +2,752 +10%
QIM
1028
Quest Investment Management
Oregon
$1.47M +$46.7K +954 +3%
HDIM
1029
Hanson & Doremus Investment Management
Vermont
$1.46M -$1.27K -26 -0.1%
EGA
1030
E&G Advisors
Texas
$1.46M -$81.8K -1,671 -5%
CD
1031
Carl Domino
Florida
$1.46M -$376K -7,687 -21%
HC
1032
HHG & Company
Connecticut
$1.45M -$51.5K -1,051 -4%
MC
1033
Mathes Company
New York
$1.45M -$48K -980 -3%
MJP
1034
Michael J. Puzo
$1.45M
SNT
1035
Security National Trust
West Virginia
$1.44M -$13.7K -279 -1%
LOCC
1036
Lombard Odier & Cie (Canada)
Quebec, Canada
$1.43M -$66.7K -1,362 -5%
MSS
1037
Mitchell Sinkler & Starr
Pennsylvania
$1.43M
PAI
1038
Pittenger & Anderson Inc
Nebraska
$1.43M +$35.1K +717 +3%
ECM
1039
EagleClaw Capital Management
Massachusetts
$1.42M
GBT
1040
Grove Bank & Trust
Florida
$1.42M +$25.2K +515 +2%
VFA
1041
Voya Financial Advisors
Connecticut
$1.41M +$318K +6,491 +30%
GAM
1042
Gould Asset Management
California
$1.41M
PIM
1043
Penobscot Investment Management
Massachusetts
$1.4M -$473K -9,655 -26%
FCT
1044
Family Capital Trust
Massachusetts
$1.4M -$125K -2,557 -8%
SC
1045
Searle & Co
Connecticut
$1.39M
PG
1046
Patten Group
Tennessee
$1.39M +$2.74K +56 +0.2%
CIC
1047
Carnegie Investment Counsel
Ohio
$1.38M +$11.8K +241 +0.9%
HL
1048
HeadInvest LLC
Maine
$1.38M +$80.8K +1,650 +6%
AA
1049
Ancora Advisors
Ohio
$1.38M
AMIM
1050
Aull & Monroe Investment Management
Alabama
$1.38M +$103K +2,096 +8%

MRK Hedge Fund Activity: Q1 2016 in Review

1,745 of the 3,754 institutional investors tracked by Wall St. Rank reported a position in Merck (MRK) for Q1 2016, worth a combined $107B — down 4.6% from $112B a quarter earlier.

Buyers outnumbered sellers: 98 funds opened new MRK positions and 83 closed out — a net gain of 15 holders — while 754 added to existing stakes and 675 trimmed.

The largest buyer was Royal London Asset Management, adding an estimated $1.82B. The largest seller was Janus Henderson Investors US, cutting an estimated $193M.

  • 1,745 institutional investors held Merck (MRK) as of Q1 2016, down from 1,755 in Q4 2015.
  • Funds reported $107B of Merck stock for Q1 2016, down 4.6% quarter-over-quarter.
  • 98 funds opened new Merck positions in Q1 2016 and 83 closed out, a net change of +15 holders.
  • The largest Merck buyer in Q1 2016 was Royal London Asset Management, an estimated $1.82B added.
  • The largest Merck seller in Q1 2016 was Janus Henderson Investors US, an estimated $193M sold.

Based on aggregated 13F filings for Q1 2016.